PubRank

A Salonia

Author PubWeight™ 21.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol 2013 1.49
2 Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J Urol 2001 1.16
3 Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000 1.07
4 Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 2001 1.01
5 Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis 2010 0.99
6 Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction. Int J Impot Res 2003 0.98
7 Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion. Eur Urol 2001 0.92
8 Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004 0.91
9 Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 1998 0.90
10 Reconfiguration of the severely fibrotic penis with a penile implant. J Urol 2001 0.89
11 Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group. Neurol Sci 2011 0.88
12 Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 2000 0.87
13 Current status of local penile therapy. Int J Impot Res 2002 0.86
14 Laparoscopic treatment of adrenal diseases: 10 years on. BJU Int 2004 0.86
15 Open prostatectomy and the evolution of HoLEP in the management of benign prostatic hyperplasia. Minerva Urol Nefrol 2009 0.85
16 Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 2005 0.83
17 Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates. Int J Clin Pract 2013 0.83
18 Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitors. Curr Pharm Des 2009 0.82
19 Erectile dysfunction in heart failure patients: a critical reappraisal. Andrology 2013 0.81
20 The ageing male and erectile dysfunction. BJU Int 2003 0.80
21 Pharmacological management of erectile dysfunction. BJU Int 2003 0.79
22 Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results. J Androl 2000 0.79
23 [Repeated ultrasound-guided transrectal prostate biopsy in patients with negative histologic test]. Arch Ital Urol Androl 2000 0.77
24 Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience. Crit Rev Oncol Hematol 2003 0.77
25 Vulvodynia: the challenge of "unexplained" genital pain. J Sex Marital Ther 2001 0.75
26 Conservative surgery in small renal tumors: our experience. Arch Esp Urol 1999 0.75
27 [Complications of multiple transrectal ultrasound-guided biopsy of the prostate]. Arch Ital Urol Androl 2000 0.75
28 Counselling the patient with prostate cancer about treatment-related erectile dysfunction. Curr Opin Urol 2001 0.75